by Dr. Reinhard Hiller | Jul 25, 2013 | Blog, Innovation management
Recently, the CPGR joined The Biomarkers Consortium. The ‘Biomarkers Consortium’, or ‘Consortium’, is a public-private scientific partnership between the Foundation for the National Institutes of Health (FNIH), the National Institutes of Health (NIH), the Food and...
by Dr. Reinhard Hiller | Jul 20, 2013 | Blog, Digital education, Online learning
A series of articles appearing on the websites of the Economist (1) and Nature (2, 3) point to the radical shifts in (higher) education brought about by advancements made in digital and online learning. It’s good to see the inklings of disruptive innovation in the...
by Dr. Reinhard Hiller | Jul 18, 2013 | Blog, Emerging markets, VC financing
A recent article on Nature’s Trade Secrets Blog1 looked at ways to measure a country’s attractiveness for biotech investment. Specifically, it explored a possible relationship between the 2013 Scientific American’s innovation scorecard data2 and the 2013 edition of a...
by Dr. Reinhard Hiller | Jul 15, 2013 | Blog, Innovation management
A July 2013 Nature Reviews Drug Discovery paper (1) highlights features of academia-industry collaborations in early-stage drug development. Specifically, the authors present a number of important points to consider when selecting a CRO (Contract Research...
Recent Comments